First clinical experience with the innova versus the protege everflex self-expanding bare metal stents in superficial femoral artery occlusions

Thoracic and Cardiovascular Surgeon

Volumn 63, Issue 2, 2015, Pages 158-163

  Gabrielli, Roberto ^a   Rosati, Maria Sofia ^a   Chiappa, Roberto ^a   Millarelli, Massimiliano ^a   Marcuccio, Luigi ^a   Siani, Andrea ^a   Caselli, Giovanni ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

endovascular interventions; femoropopliteal lesions; restenosis factors; self expanding bare metal stent system

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; HEPARIN; THROMBIN; METAL;

AGED; AMPUTATION; ANTICOAGULANT THERAPY; ARTERY OCCLUSION; ARTICLE; BARE METAL STENT; BARE METAL STENTING; BLOOD CLOT LYSIS; CLAUDICATION; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DEVICE SAFETY; DIABETES MELLITUS; EVENT FREE SURVIVAL; FALSE ANEURYSM; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN-STENT RESTENOSIS; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; RETROSPECTIVE STUDY; SELF EXPANDING NITINOL STENT; SEROMA; SMOKING; STENT FRACTURE; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY OCCLUSION; SUPERFICIAL FEMORAL ARTERY STENT; SURVIVAL RATE; THROMBECTOMY; VASCULAR CLOSURE DEVICE; VASCULAR PATENCY; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DEVICES; DISEASE FREE SURVIVAL; FEMORAL ARTERY; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RECURRENT DISEASE; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TIME; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; DISEASE-FREE SURVIVAL; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; METALS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84924676378     PISSN: 01716425     EISSN: 14391902     Source Type: Journal    
DOI: 10.1055/s-0034-1396898     Document Type: Article

References (18)

1. Crowther R. G., Spinks W. L., Leicht A. S., Sangla K., Quigley F., Golledge J. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg: 2008; 47 2 303 309
2. Robless P., Mikhailidis D. P., Stansby G. P. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev: 2008; 23 1 CD003748
3. Jackson M. R., Belott T. P., Dickason T., et al. The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts. J Vasc Surg: 2000; 32 3 498 504, 504-505
4. Dick P., Wallner H., Sabeti S., et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv: 2009; 74 7 1090 1095
5. Akopian G., Katz S. G. Peripheral angioplasty with same-day discharge in patients with intermittent claudication. J Vasc Surg: 2006; 44 1 115 118
6. Norgren L., Hiatt W. R., Dormandy J. A., Nehler M. R., Harris K. A., Fowkes F. G. TASC II Working Group Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg: 2007; 45 (Suppl S): S5 S67
7. Rocha-Singh K. J., Jaff M. R., Crabtree T. R., Bloch D. A., Ansel G. VIVA Physicians, Inc Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease. Catheter Cardiovasc Interv: 2007; 69 6 910 919
8. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med: 2006; 354 18 1879 1888
9. Becquemin J. P., Favre J. P., Marzelle J., Nemoz C., Corsin C., Leizorovicz A. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study. J Vasc Surg: 2003; 37 3 487 494
10. Grimm J., Müller-Hülsbeck S., Jahnke T., Hilbert C., Brossmann J., Heller M. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol: 2001; 12 8 935 942
11. Matsumura J. S., Yamanouchi D., Goldstein J. A., et al. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II). J Vasc Surg: 2013; 58 1 73 83.e1
12. Bosiers M., Torsello G., Gissler H. M., et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther: 2009; 16 3 261 269
13. Laird J. R., Katzen B. T., Scheinert D., et al. RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv: 2010; 3 3 267 276
14. Rutherford R. B., Baker J. D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg: 1997; 26 3 517 538
15. Gabrielli R., Rosati M. S., Vitale S., et al. Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions. J Vasc Surg: 2012; 56 6 1598 1605
16. Scheinert D., Scheinert S., Sax J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol: 2005; 45 2 312 315
17. DeRubertis B. G., Pierce M., Ryer E. J., Trocciola S., Kent K. C., Faries P. L. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg: 2008; 47 1 101 108
18. Dick F., Diehm N., Galimanis A., Husmann M., Schmidli J., Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg: 2007; 45 4 751 761